Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study

Neurology. 2001 Jul 24;57(2):368-9; author reply 369-70. doi: 10.1212/wnl.57.2.368-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use*
  • Humans
  • Longitudinal Studies
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / mortality*
  • Selegiline / adverse effects*
  • Selegiline / therapeutic use*

Substances

  • Antiparkinson Agents
  • Selegiline